» Authors » Shouzheng Wang

Shouzheng Wang

Explore the profile of Shouzheng Wang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 66
Citations 327
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang H, Liu Z, Wei P, Zhang F, Wang S, Ou-Yang W, et al.
Open Heart . 2025 Feb; 12(1). PMID: 39933829
Background: Over the past three decades, significant disparities in the global burden of cardiovascular disease (CVD) have been observed, particularly CVD attributed to secondhand smoke. However, a comprehensive understanding of...
2.
Wei P, Li Y, Xu L, Wan J, Zhang F, Tse G, et al.
Korean Circ J . 2024 Dec; PMID: 39733461
Background And Objectives: There is no dedicated occlusive device for closing coronary artery fistulas (CAFs), and specific efficacy and safety data of various off-label occlusive devices for CAFs closure are...
3.
Wei P, Feng S, Zhang F, Li H, Zhuang D, Jiang H, et al.
Catheter Cardiovasc Interv . 2024 Dec; 105(3):707-719. PMID: 39718196
Background: Mitral valve transcatheter edge-to-edge repair (M-TEER) was initially indicated for central degenerative mitral regurgitation (DMR) lesions, but advancements in technology have enabled successful treatment in an increasing number of...
4.
Gao M, Shi H, Wang C, Meng H, Wang J, Zhu D, et al.
Rev Cardiovasc Med . 2024 Dec; 25(11):413. PMID: 39618851
Background: Tricuspid transcatheter edge-to-edge repair (T-TEER) has emerged as an attractive option for severe tricuspid regurgitation (TR). To avoid the radiation exposure for both patients and medical staff, we propose...
5.
Zhu D, Wang S, Pan X
JACC Cardiovasc Interv . 2024 Oct; 17(21):2558-2560. PMID: 39387790
No abstract available.
6.
Wang S, Zhu D, Dai J, Pan X
JACC Cardiovasc Interv . 2024 Oct; 17(21):2561-2562. PMID: 39387787
No abstract available.
7.
Li Y, Xie T, Wang S, Yang L, Hao X, Wang Y, et al.
Signal Transduct Target Ther . 2024 Oct; 9(1):261. PMID: 39353908
Small-cell lung cancer (SCLC) transformation accounts for 3-14% of resistance in EGFR-TKI relapsed lung adenocarcinomas (LUADs), with unknown molecular mechanisms and optimal treatment strategies. We performed transcriptomic analyses (including bulk...
8.
Wei P, Pu Z, Chan J, Li Y, Xu L, Wan J, et al.
Catheter Cardiovasc Interv . 2024 Sep; 104(5):990-998. PMID: 39290145
Background: Coronary Artery Fistulas (CAFs) Patients with aneurysm may face severe complications, necessitating prompt treatment. However, data on the outcomes of transcatheter closure in CAFs patients with aneurysm are notably...
9.
Wang S, Liu J, Wang Y, Hu Y, Liu Z, Yao Y, et al.
Chin J Cancer Res . 2024 Sep; 36(4):398-409. PMID: 39246703
Objective: To provide real-world evidence for the application of first-line dacomitinib treatment for epidermal growth factor receptor () 21L858R mutant non-small cell lung cancer (NSCLC) patients in China and to...
10.
Liu Z, Xu J, Yin C, Han G, Che Y, Fan G, et al.
Research (Wash D C) . 2024 Aug; 7:0426. PMID: 39109248
Chest radiography is a crucial tool for diagnosing thoracic disorders, but interpretation errors and a lack of qualified practitioners can cause delays in treatment. This study aimed to develop a...